← All companies
GLUE annual revenue
Monte Rosa Therapeutics, Inc.
GLUE - CIK 0001826457
Market cap$1.40 B
Rank#2377
SEC filings352
Monte Rosa Therapeutics, Inc. revenue by year
Monte Rosa Therapeutics, Inc. (GLUE) reported revenue of $123.67M for fiscal year 2025, as filed in its audited annual report with the SEC.
GLUE revenue 2023-2025
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $123.67M | +63.5% |
| FY 2024 | $75.62M | - |
| FY 2023 | $0.00 | - |
Revenue of similar companies
Frequently asked questions
How much revenue does Monte Rosa Therapeutics, Inc. make?
Monte Rosa Therapeutics, Inc. (GLUE) reported revenue of $123.67M for fiscal year 2025, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.